Libido Research
Compounds studied in sexual function, arousal, or desire, distinct from general hormonal health.
Melanotan
Melanotan is the informal name for a family of synthetic alpha-MSH analogs originally developed for sunless tanning research. Two pharmaceutical descendants, afamelanotide (Scenesse) and bremelanotide (Vyleesi), are now FDA-approved for specific medical indications.
View research notes →
Melanotan II
Melanotan II is a synthetic alpha-MSH analog studied for skin pigmentation, sexual function, and melanocortin receptor pharmacology. It is the precursor compound that led to the development of PT-141 (bremelanotide), which is FDA-approved for women's sexual dysfunction.
View research notes →
PT-141 (Bremelanotide)
PT-141 is the only FDA-approved on-demand treatment for hypoactive sexual desire disorder in premenopausal women. Here is what the RECONNECT trial data shows, what the research limitations are, and what it costs per milligram.
View research notes →